会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • ANTIPATHOGENIC BIOMEDICAL IMPLANTS, METHODS AND KITS EMPLOYING PHOTOCATALYTICALLY ACTIVE MATERIAL
    • 抗生素生物医学植入物,使用光化学活性材料的方法和工具
    • WO2009104168A3
    • 2010-06-10
    • PCT/IB2009050715
    • 2009-02-20
    • STROEMME MARIAWELCH KENENGQVIST HAAKAN
    • STROEMME MARIAWELCH KENENGQVIST HAAKAN
    • A61L27/42A61L27/44A61L27/54
    • A61L27/54A61L2300/102A61L2300/404A61L2300/624A61L2300/63
    • An antipathogenic biomedical implant is formed throughout its structure of a matrix material comprising at least about 1 weight percent of a photocatalytically active filler which exhibits an antipathogenic effect upon irradiation with light. The photocatalytically active filler is arranged in the matrix material in the implant to receive light irradiated from an external light source. In another embodiment, an antipathogenic biomedical implant comprises at least about 1 weight percent of a photocatalytically active material which exhibits an antipathogenic effect upon irradiation with light, wherein the photocatalytically active material is arranged in the implant to receive light irradiated from an external light source. Methods for providing an antipathogenic biomedical implant, methods for reducing pathogens on a biomedical implant, methods for reducing the bioburden in a biomedical implant installation, and kits for providing an antipathogenic biomedical implant employ the antipathogenic biomedical implants.
    • 在其基质材料的整个结构中形成抗病原生物医学植入物,其包含至少约1重量%的光催化活性填料,其在用光照射时表现出抗病原作用。 将光催化活性填料布置在植入物中的基质材料中以接收从外部光源照射的光。 在另一个实施方案中,抗病原生物医学植入物包含至少约1重量%的光催化活性材料,其在照射光时表现出抗病原作用,其中所述光催化活性材料布置在植入物中以接收从外部光源照射的光。 用于提供抗病原生物医学植入物的方法,用于减少生物医学植入物上的病原体的方法,用于减少生物医学植入物装置中的生物负载的方法以及用于提供抗病原性生物医学植入物的试剂盒使用抗病原生物医学植入物。
    • 5. 发明专利
    • КРИОГЕЛИ ИЗ СОПОЛИМЕРА ВИНИЛОВОГО СПИРТА, СОПОЛИМЕРЫ ВИНИЛОВОГО СПИРТА И СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРОДУКТЫ ИЗ НИХ
    • EA018466B1
    • 2013-08-30
    • EA201100494
    • 2009-09-14
    • STROEMME MARIAMIHRANYAN ALBERT
    • STROEMME MARIAMIHRANYAN ALBERT
    • C08F8/12A61K9/00C08F218/08
    • Визобретенииобразующийкриогельсополимервиниловогоспиртапозволяетприпроведенииоперацийс нимполучатькриогель, тоестьгидрогель, полученныйв результатекриотропногогелеобразования, вводномраствореприконцентрациименьшечемприблизительно 10 мас.%, вотсутствиехимическогосшивающегоагентаи вотсутствиеэмульгатора. Криогельизсополимеравиниловогоспиртасодержитпоменьшеймереприблизительно 75 мас.% водыи сополимервиниловогоспирта, включающийомыленныйпродуктсополимеравинилацетата, полученногопоменьшеймереизприблизительно 80 мас.% мономеравинилацетатаи (i) поменьшеймереприблизительно 3 мас.% мономераакриламидаилисмесимономераакриламидаи мономераакриловойкислотыили (ii) поменьшеймереприблизительно 5 мас.% мономераакриловойкислоты. Сополимервинилацетата, сополимервиниловогоспиртаи криогельизсополимеравиниловогоспиртамогутбытьполученыв соответствиис конкретнымиспособами, акриогелиизсополимероввиниловогоспиртамогутбытьиспользованыв различныхобластяхприменения, включающихбиомедицинскиеимплантатыи тонкиепленки, идлядоставкитерапевтическихиликосметическихагентов.
    • 6. 发明专利
    • VINYL ALCOHOL CO-POLYMER CRYOGELS, VINYL ALCOHOL CO-POLYMERS, AND METHODS AND PRODUCTS THEREOF
    • CA2736833A1
    • 2010-03-18
    • CA2736833
    • 2009-09-14
    • STROEMME MARIAMIHRANYAN ALBERT
    • STROMME MARIAMIHRANYAN ALBERT
    • C08F8/12A61K9/00C08F218/08
    • A cryogel-forming vinyl alcohol co-polymer is operable to form a cryogel, i.e., a hydrogel formed by crytropic gelation, in an aqueous solution at a concentration of less than about 10% by weight, in the absence of a chemical cross-linking agent and in the absence of an emulsifier. In one embodiment, a vinyl alcohol co-polymer cryogel comprises at least about 75% by weight water and a vinyl alcohol co-polymer, wherein the vinyl alcohol co-polymer is operable to form a cryogel in an aqueous solution at a concentration of less than about 10% by weight, in the absence of a chemical cross-linking agent and in the absence of an emulsifier. In another embodiment, a vinyl alcohol co-polymer cryogel comprises at least abut 75% by weight water and a vinyl alcohol co-polymer comprising a saponified product of a vinyl acetate co- polymer formed from at least about 80% by weight of vinyl acetate monomer, and (i) at least about 3% by weight of acrylamide monomer or a mixture of acrylamide monomer and acrylic acid monomer, or (ii) at least about 5% by weight acrylic acid monomer. The vinyl acetate co- polymer, vinyl alcohol co-polymer and vinyl alcohol co-polymer cryogel may be formed according to particular methods, and the vinyl alcohol co-polymer cryogels may be used in various applications including biomedical implants and thin films and for delivery of therapeutic or cosmetic agents.